Pancreatic Cancer Research

ResearcherAzienda Ospedaliera Sant'AndreaActive in the last 2 years

Giuseppe R. Nigri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7656-7789; OpenAlex author ID A5048791548, A5089781347. Sources: OpenAlex.

Their work

Papers
17 (first author 6, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: 1 paper · 2014: 2 papers · 2015: none · 2016: 1 paper · 2017: 3 papers · 2018: 1 paper · 2019: 1 paper · 2020: 3 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 17

  1. Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort Co-author DOI 10.3390/onco5040044↗
  2. Correction to: Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective Studies. Co-author DOI 10.1007/s11605-021-05190-z↗
  3. Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective Studies. Co-author DOI 10.1007/s11605-020-04697-1↗
  4. Gynecological and reproductive factors and the risk of pancreatic cancer: A case-control study. Co-author DOI 10.1016/j.pan.2020.07.398↗
  5. Diagnostic delay does not influence survival of pancreatic cancer patients. Co-author DOI 10.1177/2050640619879004↗
  6. Corrigendum to "Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancrea… Co-author DOI 10.1016/j.ijsu.2019.05.015↗
  7. Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral uni… Co-author DOI 10.1016/j.ijsu.2018.05.025↗
  8. Neoadjuvant treatment in pancreatic cancer: Evidence-based medicine? A systematic review and meta-analysis. Co-author DOI 10.1007/s12032-017-0951-0↗
  9. Borderline resectable pancreatic cancer: an evolving concept. Co-author DOI 10.1093/annonc/mdx255↗
  10. Prognostic role of nodal ratio, LODDS, pN in patients with pancreatic cancer with venous involvement. First author DOI 10.1186/s12893-017-0311-1↗
  11. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients. First author DOI 10.1245/s10434-016-5123-5↗
  12. Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph… First author DOI 10.1016/j.pan.2014.05.794↗
  13. Is a preoperative assessment of the early recurrence of pancreatic cancer possible after complete surgical resection? First author DOI 10.5009/gnl.2014.8.1.102↗
  14. Standard retrograde pancreatosplenectomy versus radical antegrade modular pancreatosplenectomy for body and tail pancreatic adenocarcinoma. Co-author DOI 10.1177/000313481307901117↗
  15. Hospital volume, margin status, and long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. First author DOI 10.1177/000313481207800243↗
  16. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma. First author DOI 10.1245/s10434-012-2348-9↗
  17. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis. Co-author DOI 10.1002/jso.22013↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Giovanni Ramacciato · 15 shared papers, 2011–2025 · strength 1.09
  2. Niccolò Petrucciani · 10 shared papers, 2014–2025 · strength 0.91
  3. Laura Antolino · 4 shared papers, 2017–2025 · strength 0.52
  4. Francesco D’Angelo · 4 shared papers, 2017–2025 · strength 0.50
  5. Elio Jovine · 4 shared papers, 2016–2019 · strength 0.26
  6. Francesco Minni · 4 shared papers, 2016–2019 · strength 0.26
  7. Niccolò Napoli · 4 shared papers, 2016–2019 · strength 0.26
  8. Ugo Boggi · 4 shared papers, 2016–2019 · strength 0.26
  9. Antonio Daniele Pinna · 4 shared papers, 2016–2019 · strength 0.26
  10. Lívia Archibugi · 2 shared papers, 2020 · strength 0.23
  11. Gabriele Capurso · 2 shared papers, 2020 · strength 0.23
  12. Marco La Torre · 6 shared papers, 2011–2014 · strength 0.23
  13. Germana de Nucci · 1 shared paper, 2025 · strength 0.21
  14. Gianpiero Manes · 1 shared paper, 2025 · strength 0.21
  15. Vincenzo Ziparo · 5 shared papers, 2011–2014 · strength 0.19
  16. Paolo Marchetti · 2 shared papers, 2014–2020 · strength 0.16
  17. Gianpaolo Balzano · 2 shared papers, 2018–2019 · strength 0.15
  18. Caterina Stornello · 1 shared paper, 2020 · strength 0.12
  19. Giuseppe Vanella · 1 shared paper, 2020 · strength 0.12
  20. Michela Roberto · 1 shared paper, 2020 · strength 0.11
  21. Roberto Valente · 1 shared paper, 2020 · strength 0.11
  22. Genoveffa Balducci · 2 shared papers, 2013–2014 · strength 0.09
  23. Jean Gugenheim · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.